Regeneron Pharmaceuticals

Get in the Ideas Business.
At Regeneron we believe that when the right idea finds the right team, powerful change is possible.
As we work together to discover, invent, and develop biopharmaceutical medicines, we’re creating whole new ways of thinking about science, manufacturing and commercialization. And whole new ways of thinking about health.
So connect with us. Tell us about you. Learn more about our life-changing medicines. And join us, as we build a future we believe in.

Company Growth (employees)
Type
Public
HQ
Tarrytown, US
Founded
1988
Size (employees)
5,400 (est)+26%
Regeneron Pharmaceuticals was founded in 1988 and is headquartered in Tarrytown, US

Regeneron Pharmaceuticals Office Locations

Regeneron Pharmaceuticals has offices in Tarrytown, Rensselaer, Bernards, Limerick and in 1 other locations
Tarrytown, US
Dublin, IE
Limerick, IE
Bernards, US
Rensselaer, US

Regeneron Pharmaceuticals Metrics

Regeneron Pharmaceuticals Summary

Market capitalization

$40.1 b

Closing share price

$382
Regeneron Pharmaceuticals's current market capitalization is $40.1 b.

Regeneron Pharmaceuticals Financials

Regeneron Pharmaceuticals's revenue is $2.1 b in FY, 2013 which is a 25.4% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$2.1 b$2.8 b$4.1 b$4.9 b

Revenue growth, %

34%45.5%18.4%

Gross profit

$2 b$2.7 b$3.9 b

Operating expense total

$1.2 b$1.9 b$2.6 b

EBIT

$760 m$838.4 m$1.3 b

Net Income

$424.4 m$348.1 m$636.1 m$895.5 m

Operating cash flow

$305.3 m$113.1 m$160.4 m

Regeneron Pharmaceuticals Market Value History

Regeneron Pharmaceuticals Online Presence

Regeneron Pharmaceuticals News

Regeneron Pharmaceuticals Company Life

You may also be interested in